Technical analysis of Co-Diagnostics, Inc. (CODX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting.
Price Performance
| 1 month | -21.41% |
| 3 months | -70.62% |
| Year-to-date | -80.47% |
| 1 year | -92.08% |
| 3 years | -97.08% |
| 5 years | -99.67% |
52-Week Range
| 52-week High | $46.50 |
| 52-week Low | $0.94 |
| Avg Volume (90d) | 4.1M |
Technical Indicators
| SMA 50 | $1.61 |
| SMA 200 | $3.32 |
| 30-day Volatility (annualised) | 72.7% |
| Price vs SMA 50 | -38.5% |
| Price vs SMA 200 | -70.2% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $13.80 | |
| 2025-11 | $11.13 | -19.3% |
| 2025-12 | $5.07 | -54.4% |
| 2026-01 | $2.38 | -53.1% |
| 2026-02 | $2.30 | -3.4% |
| 2026-03 | $1.86 | -19.1% |
| 2026-04 | $1.55 | -16.7% |
| 2026-05 | $8.53 | +450.3% |
| 2026-06 | $3.10 | -63.7% |
| 2026-07 | $1.44 | -53.5% |
| 2026-08 | $1.24 | -13.9% |
| 2026-09 | $0.99 | -20.1% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $0.94 |
| Market Cap | $1M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.30 |
| EV / EBITDA | 0.01 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.14 |
| Current Ratio | 1.81 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -7.22 |